Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Summary

RATIONALE: Lapatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase II trial is studying how well lapatinib works in treating patients with prostate cancer that did not respond to hormone therapy.

Timeline

Start

2005-10

Primary completion

2012-07

Completion

2013-05

Drugs

Indications